Arkolith/Insider Trading/LSTA/Form 4

Mazzo David J

Chief Executive Officer, DirectorLISATA THERAPEUTICS, INC. (LSTA) · full profile →Form 4 · filed Jan 17, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 13, 2023Tax withholding(F)397$3.65$1K97K

Transaction Codes

F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001334549-23-000006) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML